Acme United Corp

Given the dominant Stage 4 decline, medium-term bias remains bearish, recommending patience for a pullback into declining EMAs before engagement. Long-term trend remains intact bullish but non-actionable. Short-term lacks a clear edge, deferring execution until a bounce into resistance confirms timing. Overall posture is to await a more favorable entry for a directional trade aligned with the medium-term downtrend.

• ↑MyMedic acquisition adds direct-to-consumer channel; first-aid sales rose 14%.
• ↑Free cash flow ~US$12M annually supports 0.43% dividend yield and capex.
• ↓Net income fell 40% to US$985K as tariffs and costs rose.